Recent News

• 09.03.2025 - 2025 Wells Fargo Healthcare Conference
• 09.03.2025 - 2025 Wells Fargo Healthcare Conference
• 09.02.2025 - Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
• 09.02.2025 - Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
• 09.02.2025 - Ascendis to Share Latest Endocrinology Rare Disease Data in 3 Oral Presentations at ASBMR 2025
• 08.28.2025 - Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference
• 08.28.2025 - Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference
• 08.28.2025 - Ascendis Pharma to Participate in the 2025 Wells Fargo Healthcare Conference

Recent Filings

• 08.29.2025 - 144 Report of proposed sale of securities
• 08.27.2025 - 144 Report of proposed sale of securities
• 08.20.2025 - 144 Report of proposed sale of securities
• 08.15.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.14.2025 - 144 Report of proposed sale of securities
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 144 Report of proposed sale of securities
• 08.13.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.13.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]